StemCell Therapy

Dublin, May 27, 2020 (GLOBE NEWSWIRE) -- The "Global Next-generation Sequencing Market By Product (Consumables, Platforms and Services), By Technology (Sequencing by Synthesis, Pyrosequencing, and Other Technologies), By End User, By Application, By Region, Competition, Forecast & Opportunities, 2025" report has been added to ResearchAndMarkets.com's offering.

The Global Next-Generation Sequencing Market is projected to grow at a CAGR of close to 20% to reach USD24 billion during the forecast period.

Enhancing regulatory framework for next-generation sequencing based tests for diagnostics is the key factor for the growth of the Global Next-Generation Sequencing Market during the forecast period. Moreover, advancements in next-generation sequencing coupled with reduction in the price of NGS platforms are some other major factors that are anticipated to bolster the growth of the Global Next-Generation Sequencing Market over the coming years. However, some of the factors that might act as major impediments to the growth of the Global Next-Generation Sequencing Market includes concerns pertaining to the standards of NGS based diagnostics.

The Global Next-Generation Sequencing Market is segmented based on product, technology, end-user, application, region and company. Based on technology, the market can be segmented into sequencing by synthesis, ion semiconductor sequencing, sequencing by ligation, pyrosequencing, single molecule real time sequencing and other technologies. Among them, the sequencing by synthesis (SBS) segment dominated the market until 2019 and is projected to grow with a healthy CAGR over the forecast period due to development of new and advanced NGS platforms along with the rising demand for Illumina's systems as it uses the SBS technology.

Major players operating in the Global Next-Generation Sequencing Market include Illumina, Inc., Thermo Fisher Scientific, Inc, BGI Group, Agilent Technologies, Inc., Qiagen N.V., Hoffmann-La Roche AG, 10x Genomics, Oxford Nanopore Technologies, Takara Bio and others.

Objective of the Study:

The author performed both primary as well as exhaustive secondary research for this study. Initially, researchers sourced a list of service providers across the globe. Subsequently, they conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, researchers could include the service providers which could not be identified due to the limitations of secondary research. The author analyzed new services, distribution channels and presence of all major players across the globe.

The author calculated the market size of the Global Next-Generation Sequencing Market by using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. Researchers sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.

Key Topics Covered:

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Next-generation Sequencing (NGS) Market Outlook5.1. Market End User & Forecast5.1.1. By Value5.2. Market Share & Forecast5.2.1. By Product (Consumables, Platforms and Services)5.2.1.1. By Consumables (Sample preparation consumables and Other Consumables)5.2.1.2. By Platforms (HiSeq series, MiSeq series, ION Torrent, SOLiD, Pacbio Rs II and Sequel system, Other Sequencing Platforms)5.2.1.3. By Services (Sequencing Services and Data management services)5.2.2. By Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real Time Sequencing and Other Technologies)5.2.3. By End User (Academic & Clinical Research Centers, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics and Others)5.2.4. By Application (Biomarkers & Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Agriculture & Animal Research and Other Applications)5.2.5. By Region5.2.6. By Company (2019)5.2.6.1. By NGS Platform

6. North America Next-generation Sequencing (NGS) Market Outlook6.1. Market End User & Forecast6.2. Market Share & Forecast6.3. North America: Country Analysis

7. Europe Next-generation Sequencing (NGS) Market Outlook7.1. Market End User & Forecast7.2. Market Share & Forecast7.3. Europe: Country Analysis

8. Asia-Pacific Next-generation Sequencing (NGS) Market Outlook8.1. Market End User & Forecast8.2. Market Share & Forecast8.3. Asia-Pacific: Country Analysis

9. Middle East and Africa Next-generation Sequencing (NGS) Market Outlook9.1. Market End User & Forecast9.2. Market Share & Forecast9.3. MEA: Country Analysis

10. South America Next-generation Sequencing (NGS) Market Outlook10.1. Market End User & Forecast10.2. Market Share & Forecast10.3. South America: Country Analysis

11. Market Dynamics11.1. Drivers11.2. Challenges

12. Market Trends & Developments

13. Competitive Landscape (NGS Platform Providers)13.1. Competition Outlook13.2. Company Profiles13.2.1. Illumina, Inc.13.2.2. Thermo Fisher Scientific, Inc13.2.3. BGI Group13.2.4. Perkinelmer13.2.5. Agilent Technologies, Inc.13.2.6. Qiagen N.V.13.2.7. F. Hoffmann-La Roche AG13.2.8. 10x Genomics13.2.9. Oxford Nanopore Technologies13.2.10. Takara Bio

14. Strategic Recommendations

15. About Us & Disclaimer

For more information about this report visit https://www.researchandmarkets.com/r/2rcwyi

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Read the rest here:
Insights on the Worldwide Next-generation Sequencing Industry to 2025 - Featuring Illumina, BGI Group & Perkinelmer Among Others - GlobeNewswire

This entry was posted on May 27, 2020 at 11:47 am and is filed under Personalized Medicine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |